Breaking News Instant updates and real-time market news.

ELLI

Ellie Mae

$84.34

0.14 (0.17%)

07:14
09/13/17
09/13
07:14
09/13/17
07:14

Ellie Mae recent selloff provides buying opportunity, says Oppenheimer

Oppenheimer analyst Brian Schwartz believes the recent sell-off in Ellie Mae provides investors with an opportunity to buy a category leader at an attractive valuation. The analyst notes that the company's momentum in bookings, customer acquisition, and loan volumes remains healthy, and its technology leadership in the market will extend in 4Q from new tech announcements and the Velocify closing. He reiterates an Outperform rating and $101 price target on the shares.

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

ELLI Ellie Mae
$84.34

0.14 (0.17%)

07/28/17
OPCO
07/28/17
NO CHANGE
Target $101
OPCO
Outperform
Oppenheimer likes Ellie Mae risk/reward after 'disappointing' Q2 report
Oppenheimer analyst Brian Schwartz expects consensus estimates will be "cut hard" after Ellie Mae's Q2 miss and guide down, but he likes the risk/reward opportunity with the worst of the cycle headwinds now behind it. He lowered his price target on the stock to $101 from $125 but maintains an Outperform rating on Ellie Mae shares, which are down about 25% in pre-market trading to $82.80.
07/28/17
ROTH
07/28/17
DOWNGRADE
ROTH
Neutral
Ellie Mae downgraded to Neutral from Buy at Roth Capital
08/14/17
NEED
08/14/17
NO CHANGE
Target $100
NEED
Buy
Ellie Mae temporary setback a buying opportunity, says Needham
After meeting with management, Needham analyst Mayank Tandon is confident that Ellie Mae's competitive position remains "strong" and it can continue to expand its already dominant market share and return to 25% revenue growth once industry mortgage volumes stabilize. Further, the analyst believes management has largely de-risked the 2H guide with a conservative set of assumptions for the key revenue drivers, and thinks risk-reward is favorable following the recent 20% drop in the shares. Tandon reiterates a Buy rating with a $100 target on the shares.
09/01/17
JPMS
09/01/17
NO CHANGE
Target $112
JPMS
Overweight
Ellie Mae acquisition positive, but Harvey a headwind, says JPMorgan
JPMorgan analyst Sterling Auty views Ellie Mae's acquisition of Velocify positively. The deal should build the company's subscription revenue opportunity at a time when mortgage lenders are shifting more attention to home purchase mortgages relative to refinances, Auty tells investors in a research note. The analyst, however, views Hurricane Harvey as a headwind. He lowered his non-contracted revenue estimates for Ellie by $1M in both Q3 and Q4 to account for a potential significant slowdown in the Houston housing market. Auty keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

STAA

STAAR Surgical

$10.90

0.05 (0.46%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Upgrade
STAAR Surgical rating change  »

STAAR Surgical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.32

0.24 (2.64%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Technical Analysis
Technical View: Transocean trades higher in pre-market, analyst action »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

ZG

Zillow

$38.93

-0.93 (-2.33%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Initiation
Zillow initiated  »

Zillow initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

AMAT

Applied Materials

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Applied Materials analyst commentary  »

Applied Materials analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AEM

Agnico Eagle

$46.74

0.6 (1.30%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Agnico Eagle analyst commentary  »

Agnico Eagle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

DK

Delek US

$25.70

0.25 (0.98%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Conference/Events
Delek US management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

APOP

Cellect Biotechnology

$8.28

0.19 (2.35%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Recommendations
Cellect Biotechnology analyst commentary  »

Cellect Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPX

Louisiana-Pacific

$28.44

0.53 (1.90%)

07:21
09/25/17
09/25
07:21
09/25/17
07:21
Recommendations
Louisiana-Pacific analyst commentary  »

Louisiana-Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSO

CytoSorbents

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Hot Stocks
CytoSorbents highlights publication of study in Journal of Artificial Organs »

CytoSorbents highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMD

CorMedix

$0.47

0.048 (11.37%)

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Recommendations
CorMedix analyst commentary  »

CorMedix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
09/25/17
09/25
07:20
09/25/17
07:20
General news
FX Update: The euro has come under across-the-board pressure »

FX Update: The euro has…

TWTR

Twitter

$17.61

0.03 (0.17%)

07:19
09/25/17
09/25
07:19
09/25/17
07:19
Periodicals
Twitter tests Twitter Lite Android app in the Philippines, TechCrunch says »

Twitter is testing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

, NBL

Noble Energy

$27.02

0.07 (0.26%)

07:18
09/25/17
09/25
07:18
09/25/17
07:18
Hot Stocks
Noble Midstream now sees Q3 net income $42M-$43M »

Noble Midstream Partners…

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

NBL

Noble Energy

$27.02

0.07 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 31

    Oct

NOC

Northrop Grumman

$281.55

1.13 (0.40%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Hot Stocks
Northrop Grumman announces support contract for U.K. CUTLASS vehicles »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$150.14

0.95 (0.64%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CSIQ

Canadian Solar

$16.46

0.6 (3.78%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Hot Stocks
Tokyo Stock Exchange approves listing of Canadian Solar Infrastructure Fund »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$74.19

5.35 (7.77%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$142.82

-0.1 (-0.07%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Recommendations
Alexion analyst commentary  »

Alexion Soliris to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 23

    Oct

SGYP

Synergy Pharmaceuticals

$2.59

-0.05 (-1.89%)

07:15
09/25/17
09/25
07:15
09/25/17
07:15
Recommendations
Synergy Pharmaceuticals analyst commentary  »

Synergy Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 24

    Jan

OB

Onebeacon Insurance

$18.11

0.01 (0.06%)

07:14
09/25/17
09/25
07:14
09/25/17
07:14
Hot Stocks
All regulatory approvals obtained for Intact Financial's acquisition of Onebeacon Insurance »

OneBeacon Insurance Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels & Resorts

$20.85

0.25 (1.21%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Hot Stocks
Xenia Hotels & Resorts provides update on Hyatt Centric Key West Resort & Spa »

Xenia Hotels &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

, BABA

Alibaba

$178.14

0.75 (0.42%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Periodicals
Amazon launches Kindle promotion with Alibaba, Recode reports »

Amazon (AMZN) launched a…

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

BABA

Alibaba

$178.14

0.75 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

CL

Colgate-Palmolive

$71.19

-0.18 (-0.25%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Upgrade
Colgate-Palmolive rating change  »

Colgate-Palmolive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$134.29

-0.6 (-0.44%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Downgrade
Albemarle rating change  »

Albemarle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ADNT

Adient

$82.95

0.71 (0.86%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Hot Stocks
Adient sees Futuris Group acquisition adding about $500M in annual revenue »

Adient announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.